Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Kappeler, C.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(7)
+
-
Availability
Metadata Only
(7)
+
-
Creation Date
2013
(5)
+
-
Faculty
Leiden University Medical Center (LUMC)
(7)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(7)
+
-
Author
Kappeler, C.
(7)
+
-
Blay, J.Y.
(6)
+
-
Demetri, G.D.
(6)
+
-
Gelderblom, H.
(6)
+
-
Hohenberger, P.
(6)
+
-
Kang, Y.K.
(6)
+
-
Kuss, I.
(6)
+
-
Reichardt, P.
(6)
+
-
Rutkowski, P.
(6)
+
-
Badalamenti, G.
(5)
+
-
Casali, P.G.
(5)
+
-
Cesne, A. le
(5)
+
-
Joensuu, H.
(5)
+
-
Maki, R.G.
(5)
+
-
Mehren, M. von
(5)
+
-
Nishida, T.
(5)
+
-
Schoffski, P.
(5)
+
-
Bauer, S.
(4)
+
-
Xu, J.M.
(4)
+
-
Blackstein, M.
(3)
+
-
Chung, J.
(3)
+
-
Leahy, M.
(3)
+
-
Blackstein, M.E.
(2)
+
-
Laurent, D.
(2)
+
-
Leahy, M.G.
(2)
+
-
Nguyen, B.B.
(2)
+
-
Show more
Language
en
(7)
+
-
Search results
(1 - 7 of 7)
show grid
show list
save search
Reichardt, P.; Joensuu, H.; Casali, P.G.; Kang, Y.K.; Blay, J.Y.; Rutkowski, P.; ... ; Demetri, G.D.
2014
Results from a phase III trial (GRID) evaluating regorafenib (REG) in metastatic gastrointestinal stromal tumour (GIST): Subgroup analysis of outcomes based on pretreatment characteristics
Article / Letter to editor
metadata only
Bauer, S.; Joensuu, H.; Casali, P.; Reichardt, P.; Kang, Y.K.; Blay, J.Y.; ... ; Demetri, G.D.
2013
Results from a phase III trial (GRID) evaluating regorafenib in metastatic gastrointestinal stromal tumour (GIST): Subgroup analysis of outcomes based on pretreatment characteristics
Article / Letter to editor
metadata only
Bauer, S.; Blay, J.Y.; Casali, P.G.; Reichardt, P.; Kang, Y.K.; Rutkowski, P.; ... ; Demetri, G.D.
2013
Time course of adverse events in the phase III GRID study of regorafenib in patients with metastatic gastrointestinal stromal tumors (GIST)
Article / Letter to editor
metadata only
Joensuu, H.; Casali, P.G.; Reichardt, P.; Kang, Y.K.; Blay, J.Y.; Rutkowski, P.; ... ; Demetri, G.D.
2013
Results from a phase III trial (GRID) evaluating regorafenib (REG) in metastatic gastrointestinal stromal tumour (GIST) Subgroup analysis of outcomes based on pretreatment characteristics
Article / Letter to editor
metadata only
Demetri, G.D.; Jeffers, M.; Reichardt, P.; Kang, Y.K.; Blay, J.Y.; Rutkowski, P.; ... ; Casali, P.G.
2013
Detection of oncogenic kinase mutations in circulating plasma DNA and correlation with clinical benefit in the phase III GRID study of regorafenib vs placebo in TKI-refractory metastatic GIST
Article / Letter to editor
metadata only
Demetri, G.D.; Reichardt, P.; Kang, Y.K.; Blay, J.Y.; Rutkowski, P.; Gelderblom, H.; ... ; GRID Study Investigators
2013
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Article / Letter to editor
metadata only
Brose, M.S.; Nutting, C.M.; Sherman, S.I.; Shong, Y.K.; Smit, J.W.A.; Reike, G.; ... ; Schlumberger, M.
2011
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer
Article / Letter to editor
metadata only
